“…To date, most of the methylation studies in gastric neoplasms have focused on aberrant methylation of a single gene in carcinomas (Kanai et al, 1998;Iida et al, 2002;Fujimoto et al, 2000;Tsuchiya et al, 2000;Kang et al, 2002). Recent data, however, suggest that there is concordant methylation of multiple genes (termed CpG-island methylation phenotype, CIMP) (Toyota et al, 1999a) in carcinomas from diverse sites including uterine cervix, colorectum, biliary tree, pancreas, bladder, nasopharynx, esophagus, and stomach (Toyota et al, 1999a, b;Eads et al, 2000Eads et al, , 2001Kang et al, 2001;Leung et al, 2001;Maruyama et al, 2001Maruyama et al, , 2002Ueki et al, 2001;Virmani et al, 2001;Lee et al, 2002a, b;Kwong et al, 2002). Concordant methylation of multiple loci has been described in 41% of gastric cancer (Toyota et al, 1999b).…”